A carregar...
Spiromax, a New Dry Powder Inhaler: Dose Consistency under Simulated Real-World Conditions
Background: Spiromax(®) is a novel dry powder inhaler for patients with asthma or chronic obstructive pulmonary disease (COPD). The studies presented here provide further data on attributes (in vitro dosing consistency with budesonide–formoterol (DuoResp) Spiromax; flow rates through empty versions...
Na minha lista:
| Publicado no: | J Aerosol Med Pulm Drug Deliv |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Mary Ann Liebert, Inc.
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4601554/ https://ncbi.nlm.nih.gov/pubmed/26352860 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/jamp.2015.1216 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|